Considering the role of radical prostatectomy in 21st century prostate cancer care

AJ Costello - Nature Reviews Urology, 2020 - nature.com
The practice of radical prostatectomy for treating prostate cancer has evolved remarkably
since its general introduction around 1900. Initially described using a perineal approach, the …

Defining clinically significant prostate cancer on the basis of pathological findings

A Matoso, JI Epstein - Histopathology, 2019 - Wiley Online Library
The definition of clinically significant prostate cancer is a dynamic process that was initiated
many decades ago, when there was already evidence that a great proportion of patients with …

[HTML][HTML] Follow-up of prostatectomy versus observation for early prostate cancer

TJ Wilt, KM Jones, MJ Barry, GL Andriole… - … England Journal of …, 2017 - Mass Medical Soc
Background We previously found no significant differences in mortality between men who
underwent surgery for localized prostate cancer and those who were treated with …

[HTML][HTML] Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer

JJ Tosoian, M Mamawala, JI Epstein… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose To assess long-term outcomes of men with favorable-risk prostate cancer in a
prospective, active-surveillance program. Methods Curative intervention was recommended …

[HTML][HTML] A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse …

J Cullen, IL Rosner, TC Brand, N Zhang, AC Tsiatis… - European urology, 2015 - Elsevier
Background Biomarkers that are validated in independent cohorts are needed to improve
risk assessment for prostate cancer (PCa). Objective A racially diverse cohort of men (20 …

Prostate cancer, version 2.2014

JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014 - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …

Joint prostate cancer detection and Gleason score prediction in mp-MRI via FocalNet

R Cao, AM Bajgiran, SA Mirak… - IEEE transactions on …, 2019 - ieeexplore.ieee.org
Multi-parametric MRI (mp-MRI) is considered the best non-invasive imaging modality for
diagnosing prostate cancer (PCa). However, mp-MRI for PCa diagnosis is currently limited …

[HTML][HTML] An eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer

S Wang, W Su, C Zhong, T Yang, W Chen… - Frontiers in Cell and …, 2020 - frontiersin.org
Prostate cancer (PCa) is a high morbidity malignancy in males, and biochemical recurrence
(BCR) may appear after the surgery. Our study is designed to build up a risk score model …

MRI–ultrasound fusion for guidance of targeted prostate biopsy

L Marks, S Young, S Natarajan - Current opinion in urology, 2013 - journals.lww.com
MRI–ultrasound fusion for guidance of targeted prostate biop... : Current Opinion in Urology
MRI–ultrasound fusion for guidance of targeted prostate biopsy : Current Opinion in Urology …

Medium-term outcomes of active surveillance for localised prostate cancer

ED Selvadurai, M Singhera, K Thomas, K Mohammed… - European urology, 2013 - Elsevier
Background Active surveillance (AS) aims to allow men with favourable-risk, localised
prostate cancer to avoid unnecessary treatment. Objective To describe the clinical outcomes …